Literature DB >> 10221704

Fertility of ejaculated and testicular megalohead spermatozoa with intracytoplasmic sperm injection.

S Kahraman1, C Akarsu, G Cengiz, K Dirican, E Sözen, B Can, C Güven, P Vanderzwalmen.   

Abstract

In this study the fertility and outcome of intracytoplasmic sperm injection (ICSI) using megalohead spermatozoa from the ejaculates and testicles was evaluated. Seventeen males with megalohead and pinhead sperm forms in their ejaculate were studied in 22 cycles. A high number of sperm heads without tails and abundant round spermatid forms were commonly observed. Round-headed spermatozoa were seldom accompanied by these severely abnormal spermatozoa. The majority of megalohead spermatozoa were observed to have multiple tails, were predominant in the sample, and were used for ICSI. Ejaculated megalohead spermatozoa were used for ICSI in 15 cycles, while testicular spermatozoa were used in seven cycles where there were no vital spermatozoa or spermatozoa of low vitality in the ejaculate. The same abnormal morphology was observed in the testicles as in the ejaculated spermatozoa in the same males. Mean (+/- SD) low motility 4.7 +/- 5.6% and sperm count (3.8 +/- 4.19 x 10(6)) were common findings in these severely teratozoospermic patients. A low fertilization rate (43.2%) was achieved by using megalohead sperm forms (group I, n = 17) in comparison with the control group (60.2%) which had zero normal sperm morphology according to strict criteria (group II, n = 30) (P <0.01). Furthermore, a low pregnancy rate (9.1%) was obtained in the megalohead sperm group in comparison with the control group (40%) (P <0.05). Low fertilization and pregnancy rates may be due to a high incidence of chromosomal abnormalities from severely defective spermatozoa in the ejaculate. Couples should be counselled and warned about possible low fertilization and pregnancy rates with ICSI when only pinhead and megalohead forms with a high number of sperm heads without tails are present in the ejaculate.

Entities:  

Mesh:

Year:  1999        PMID: 10221704     DOI: 10.1093/humrep/14.3.726

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Clinical significance of the low normal sperm morphology value as proposed in the fifth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen.

Authors:  Roelof Menkveld
Journal:  Asian J Androl       Date:  2010-01       Impact factor: 3.285

Review 2.  Measurement and significance of sperm morphology.

Authors:  Roelof Menkveld; Cas A G Holleboom; Johann P T Rhemrev
Journal:  Asian J Androl       Date:  2010-11-15       Impact factor: 3.285

Review 3.  Focus on intracytoplasmic morphologically selected sperm injection (IMSI): a mini-review.

Authors:  Giuseppe Lo Monte; Fabien Murisier; Isabella Piva; Marc Germond; Roberto Marci
Journal:  Asian J Androl       Date:  2013-07-08       Impact factor: 3.285

4.  Effect of erythrocyte-sperm separation medium on nuclear, acrosomal, and membrane maturity parameters in human sperm.

Authors:  Bikem Soygur; Soner Celik; Ciler Celik-Ozenci; Leyla Sati
Journal:  J Assist Reprod Genet       Date:  2017-11-18       Impact factor: 3.412

5.  Is intracouple assisted reproductive technology an option for men with large-headed spermatozoa? A literature review and a decision guide proposal.

Authors:  Bruno Guthauser; Xavier Pollet-Villard; Florence Boitrelle; Francois Vialard
Journal:  Basic Clin Androl       Date:  2016-07-08

6.  Intracytoplasmic Sperm Injection with Assisted Oocyte Activation Resulting in Successful Pregnancies and Live Birth in Couples with Globozoospermia: A Report of Two Cases.

Authors:  Puneet Kaur Kochhar; Pranay Ghosh
Journal:  J Hum Reprod Sci       Date:  2018 Jan-Mar

7.  Sperm morphology and DNA fragmentation after zona pellucida selection.

Authors:  Rumiana Ganeva; Dimitar Parvanov; Denitsa Velikova; Magdalena Vasileva; Kristina Nikolova; Georgi Stamenov
Journal:  Reprod Fertil       Date:  2021-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.